explore -WSS

explore

author：entertainment 2025-10-01 21:37:17 - browse：6119

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

WSS

Ethical issues complicate the benefits of medical crowdfunding

Scientists find bacteria from stomach of ancient iceman

Stem cell treatment guidelines are released by FDA

The (many) problems with a new study criticizing cancer screening

Weighted lottery helped low

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

leisure time

explore

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Illumina names Agilent executive as new CEO

Medicare details structure of new drug price negotiation program

What drug price negotiations mean for Medicare Part D

At least 13 dead in Texas as scorching temps continue

The 10 drugs up first for Medicare price negotiation

The cancer drug shortage isn’t new — and neither are the solutions

Illumina names Agilent executive as new CEO

In Memoriam: Notable people who died in 2023

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

entertainment

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Covid hospitalizations on the rise, Humana says

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

NIH nominee Bertagnolli will get October confirmation hearing

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

focus

hotspot

explore

focus